State Ledger
Company profile

Allogene Therapeutics, Inc. CIK 1737287

Ticker
ALLO (Nasdaq)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
South San Francisco, CA 94080
Fiscal year end
2025 (FY)
Market Data
Close
$1.46
Change
+$0.06
Change %
3.93%
Volume
327,543

ALLO · trading date Oct 9, 2026 · previous close $1.40 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$0
Net income
-$190.89M
Total assets
$415.91M
Total liabilities
$123.36M
Stockholders' equity
$292.54M
Cash & equivalents
$51.69M
Operating income
-$209.32M
Operating cash flow
-$149.25M
Capital expenditures
$386.0K

Fiscal year 2025, via 10-K filed 2026-03-12. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$149.63M
Free cash flow margin
—
Liabilities / assets
29.7%
Equity / assets
70.3%
CapEx / revenue
—
Operating cash flow / net income
0.78×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $0 -$190.89M $415.91M $123.36M $292.54M
2024 $22.0K -$257.59M $548.71M $126.53M $422.18M
2023 $95.0K -$327.27M $642.84M $130.60M $512.23M
2022 $156.0K -$340.41M $821.58M $154.70M $666.88M
2021 $114.09M -$182.05M $1.05B $125.63M $925.20M
Company Details
SIC code
2836
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-02
Financials filed via
Form 10-K
filed 2026-03-12

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
South San Francisco, CA 94080
210 EAST GRAND AVENUE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 16:04 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies